Effect of severe renal impairment on umeclidinium and umeclidinium/vilanterol pharmacokinetics and safety: a single-blind, nonrandomized study

por Mehta, Rashmi, Hardes, Kelly, Brealey, Noushin, Tombs, Lee, Preece, Andrew, Kelleher, Dennis
Publicado 2014

A Phase 1 study of the long‐acting anti‐IL‐5 monoclonal antibody GSK3511294 in patients with asthma

por Singh, Dave, Fuhr, Rainard, Bird, Nicholas P., Mole, Sarah, Hardes, Kelly, Man, Yau Lun, Cahn, Anthony, Yancey, Steven W., Pouliquen, Isabelle J.
Publicado 2021

A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome

por Khan, Akram, Benthin, Cody, Zeno, Brian, Albertson, Timothy E., Boyd, John, Christie, Jason D., Hall, Richard, Poirier, Germain, Ronco, Juan J., Tidswell, Mark, Hardes, Kelly, Powley, William M., Wright, Tracey J., Siederer, Sarah K., Fairman, David A., Lipson, David A., Bayliffe, Andrew I., Lazaar, Aili L.
Publicado 2017

A nebulised antitumour necrosis factor receptor-1 domain antibody in patients at risk of postoperative lung injury: A randomised, placebo-controlled pilot study

por Ryan, James, Bayliffe, Andrew I., McAuley, Daniel F., Yeung, Joyce, Thickett, David R., Howells, Phillip A., O’Donnell, Ciara, Vassallo, Arlette M., Wright, Tracey J., McKie, Elizabeth, Hardes, Kelly, Summers, Charlotte, Shields, Martin O., Powley, William, Wilson, Robert, Lazaar, Aili L., Fowler, Andrew, Perkins, Gavin D.
Publicado 2020